Literature DB >> 15300798

Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma.

Dipok Kumar Dhar1, Hiroyuki Naora, Hirofumi Kubota, Riruke Maruyama, Hiroshi Yoshimura, Yasuhito Tonomoto, Mitsuo Tachibana, Takashi Ono, Hiroki Otani, Naofumi Nagasue.   

Abstract

KiSS-1 is a promising candidate tumor-suppressor gene and may play a key role in the metastatic cascade. The expression profile and the role of KiSS-1 in cancer progression are largely unknown in most of the cancers, including gastric cancer. In this study, KiSS-1 expression was evaluated by RNase protection assay and localization was done by in situ hybridization in 40 gastric cancers and their adjacent normal gastric mucosa. For comparison with clinicopathologic characteristics and patient prognosis, all patients were divided into 2 groups having high and low KiSS-1 expression by using the median as the cutoff value of KiSS-1 expression as determined by the RNase protection assay. Gastric cancers with low KiSS-1 had frequent venous invasion, distant metastasis and tumor recurrence. Accordingly, patients with low KiSS-1-expressing tumors had a significantly worse overall and disease-free survival. In multivariate analysis, KiSS-1 became the strongest independent prognostic factor among the conventional prognosticators for gastric cancer patients. Collectively, these findings suggest that KiSS-1 may play a crucial role in gastric cancer invasion and could be a useful target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300798     DOI: 10.1002/ijc.20357

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  52 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  KiSS-1 expression in human breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Kisspeptin-54 levels are increased in patients with colorectal cancer.

Authors:  Emel Canbay; Arzu Ergen; Dursun Bugra; Sumer Yamaner; Ilhan Yaylim Eraltan; Yilmaz Buyukuncu; Turker Bulut
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

Review 4.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

5.  KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study.

Authors:  Katharina Schmid; Xiaowei Wang; Andrea Haitel; Wolfang Sieghart; Markus Peck-Radosavljevic; Martin Bodingbauer; Susanne Rasoul-Rockenschaub; Fritz Wrba
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

6.  Metastin is not involved in metastatic potential of non-small cell lung cancer.

Authors:  Eleni M Karapanagiotou; Kalliopi D Dilana; Ioannis Gkiozos; Ioannis Gratsias; Sotirios Tsimpoukis; Aris Polyzos; Kostas N Syrigos
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.064

7.  Q36R polymorphism of KiSS-1 gene in Brazilian head and neck cancer patients.

Authors:  Mariângela Torreglosa Ruiz; Ana Lívia Silva Galbiatti; Erika Cristina Pavarino; José Victor Maniglia; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2012-01-01       Impact factor: 2.316

Review 8.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

Authors:  Kevin T Nash; Danny R Welch
Journal:  Front Biosci       Date:  2006-01-01

9.  KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.

Authors:  Marianna Yaron; Ulrich Renner; Suzan Gilad; Günter K Stalla; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

10.  Kisspeptin 10 inhibits the Warburg effect in breast cancer through the Smad signaling pathway: both in vitro and in vivo.

Authors:  Guo-Qing Song; Yi Zhao
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.